WATSON 760 Pill - beige round
Pill with imprint WATSON 760 is Beige, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Watson Pharmaceuticals.
Ranitidine is used in the treatment of GERD; Erosive Esophagitis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Cutaneous Mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 760
Ranitidine Hydrochloride
- Imprint
- WATSON 760
- Strength
- 150 mg
- Color
- Beige
- Shape
- Round
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals
- National Drug Code (NDC)
- 00364-2633 (Discontinued)
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (165)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
- Ranitidine drug information
- Ranitidine Tablets and Capsules
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
